Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
作者信息
Strand V, Landéwé R, van der Heijde D
机构信息
Stanford University, Division of Immunology, Palo Alto, CA, USA.
出版信息
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii64-6. doi: 10.1136/ard.61.suppl_2.ii64.
Abstract
摘要
相似文献
1
Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.利用估计的年进展率比较类风湿关节炎近期随机对照试验中的影像学数据。
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii64-6. doi: 10.1136/ard.61.suppl_2.ii64.
2
Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?类风湿关节炎近期随机对照试验的影像学数据：我们学到了什么？
Arthritis Rheum. 2003 Jan;48(1):21-34. doi: 10.1002/art.10683.
3
Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.类风湿关节炎的影像学进展：三项对照试验的结果
J Rheumatol. 1995 Sep;22(9):1797-9.
4
Interpreting radiographic data in rheumatoid arthritis.类风湿关节炎的影像学数据解读
Ann Rheum Dis. 2003 Jul;62(7):597-604. doi: 10.1136/ard.62.7.597.
5
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].抗风湿药物（DMARDs）对类风湿关节炎影像学进展的抑制作用
Clin Calcium. 2007 Apr;17(4):546-52.
6
How to interpret radiological progression in randomized clinical trials?如何解读随机临床试验中的影像学进展？
Rheumatology (Oxford). 2003 Jan;42(1):2-5. doi: 10.1093/rheumatology/keg062.
7
Should radiographic progression still be used as outcome in RA?影像学进展是否仍应作为 RA 的结局指标？
Clin Immunol. 2018 Jan;186:79-81. doi: 10.1016/j.clim.2017.07.022. Epub 2017 Jul 22.
8
Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis?在早期炎症性关节炎的临床试验中，影像学进展是否是一个现实的疗效指标？
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S37-41.
9
Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.改善病情抗风湿药、糖皮质激素和生物制剂对类风湿关节炎影像学进展的类似影响：对70项随机安慰剂对照或药物对照研究的荟萃分析，包括112项比较。
Arthritis Rheum. 2010 Oct;62(10):2852-63. doi: 10.1002/art.27592.
引用本文的文献
1
Biological function integrated prediction of severe radiographic progression in rheumatoid arthritis: a nested case control study.类风湿关节炎严重放射学进展的生物学功能综合预测：巢式病例对照研究。
Arthritis Res Ther. 2017 Oct 25;19(1):244. doi: 10.1186/s13075-017-1414-x.
2
PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.PTGER4基因变体rs76523431是类风湿关节炎患者放射性关节损伤的候选风险因素：一项对六个队列的遗传学研究。
Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.
3
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.骨保护素基因变异与类风湿关节炎关节破坏进展相关。
Arthritis Res Ther. 2014 May 7;16(3):R108. doi: 10.1186/ar4558.
4
Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis.自身抗体阳性类风湿关节炎关节损伤进展的遗传变异鉴定。
Ann Rheum Dis. 2014 Nov;73(11):2038-46. doi: 10.1136/annrheumdis-2013-204050. Epub 2013 Aug 16.
5
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.托珠单抗治疗类风湿关节炎患者的临床、影像学和功能疗效：REACTION 52 周研究。
Rheumatology (Oxford). 2011 Oct;50(10):1908-15. doi: 10.1093/rheumatology/ker221. Epub 2011 Jul 13.
6
Anakinra for rheumatoid arthritis.阿那白滞素用于治疗类风湿关节炎。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD005121. doi: 10.1002/14651858.CD005121.pub3.
7
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial.阿巴西普可抑制类风湿关节炎的结构损伤进展：AIM试验长期扩展研究结果
Ann Rheum Dis. 2008 Aug;67(8):1084-9. doi: 10.1136/ard.2007.085084. Epub 2007 Dec 17.
8
Remission, a therapeutic goal in inflammatory arthropathies? Clinical data from adalimumab studies.缓解，炎性关节病的治疗目标？来自阿达木单抗研究的临床数据。
Drugs. 2006;66(14):1783-95. doi: 10.2165/00003495-200666140-00001.
9
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up.类风湿关节炎中以放射学检查作为主要结局：随访3个月的试验的可接受样本量
Ann Rheum Dis. 2004 Nov;63(11):1413-8. doi: 10.1136/ard.2003.014043. Epub 2004 Mar 22.
本文引用的文献
1
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.依那西普与甲氨蝶呤治疗早期类风湿关节炎患者的两年影像学及临床疗效对比
Arthritis Rheum. 2002 Jun;46(6):1443-50. doi: 10.1002/art.10308.
2
Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
Arthritis Rheum. 2001 Nov;44(11):2703-4. doi: 10.1002/1529-0131(200111)44:11<2703::aid-art451>3.0.co;2-e.
3
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.来氟米特与甲氨蝶呤治疗活动性类风湿关节炎的两年双盲随机对照试验。类风湿关节炎治疗中来氟米特应用试验研究组。
Arthritis Rheum. 2001 Sep;44(9):1984-92. doi: 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B.
4
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.来氟米特治疗活动性类风湿关节炎：一项与柳氮磺胺吡啶对比的双盲、安慰剂对照试验的两年随访
Ann Rheum Dis. 2001 Oct;60(10):913-23. doi: 10.1136/ard.60.10.913.
5
Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
J Rheumatol. 2001 Apr;28(4):887-9.
6
Radiography of rheumatoid arthritis in the time of increasing drug effectiveness.
Curr Rheumatol Rep. 2001 Feb;3(1):46-52. doi: 10.1007/s11926-001-0050-1.
7
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.英夫利昔单抗与甲氨蝶呤治疗类风湿关节炎。类风湿关节炎联合治疗抗肿瘤坏死因子试验研究组。
N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.
8
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.早期类风湿关节炎患者中依那西普与甲氨蝶呤的比较。
N Engl J Med. 2000 Nov 30;343(22):1586-93. doi: 10.1056/NEJM200011303432201.
9
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.来氟米特与甲氨蝶呤治疗类风湿关节炎的疗效及安全性比较。
Rheumatology (Oxford). 2000 Jun;39(6):655-65. doi: 10.1093/rheumatology/39.6.655.
10
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.一项关于重组人白细胞介素-1受体拮抗剂治疗类风湿关节炎患者的多中心、双盲、剂量范围、随机、安慰剂对照研究：影像学进展及Genant和Larsen评分的相关性
Arthritis Rheum. 2000 May;43(5):1001-9. doi: 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P.
Zotero 插件